- Live Meeting -

Safe Handling of Hazardous Drugs: Risks and Practical Considerations

Program Description

Hazardous drugs include potent and toxic agents that may cause immediate and long-term negative health effects in exposed workers. While recommendations for safe work practices have been in effect for decades, new studies show continuing contamination in the workplace and uptake of drugs into workers. This presentation will include the results of new studies on contamination and the use of new biomarkers as evidence of the consequences of exposure to hazardous drugs. An analysis of workplace practices that contribute to contamination and those that are useful in reducing exposure also will be presented.

Program Location

The Venetian Resort Hotel Casino
Casanova Ballroom, Room 505 - 507 (Lower Level)
3355 Las Vegas Blvd. South
Las Vegas, NV

Program Agenda

6:30 AM - 7:00 AM Registration and Breakfast
7:00 AM - 8:30 AM CE Presentation 

Learning Objectives

The target audience for this program is pharmacists in health-system settings. At the completion of this program, the participant will be able to:

• Define hazardous drugs and negative health effects associated with exposure

• Identify work practices that present a risk of exposure to hazardous drugs

• Outline workplace strategies and practices to reduce exposure and prevent contamination from hazardous drugs

• Describe technological advances that may reduce the exposure of healthcare providers to hazardous drugs during handling

Program Faculty

Thomas H. Connor, PhD
Research Biologist
Division of Applied Research and Technology
National Institute for Occupational Safety and Health
Cincinnati, OH

Luci A. Power, MS, RPh
Senior Pharmacy Consultant
Power Enterprises
San Francisco, CA

CE Accreditation

Pharmacists
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-000-09-089-L05-P has been assigned to this live knowledge-based program (initial release date 12-07-09). This program is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Statements of credit will be issued online at www.ProCE.com upon successful completion of the program evaluation. Participants must complete a program evaluation to receive pharmacy CE credit. No partial credit will be given.

Funding

This program is supported by an educational grant from ICU Medical, Inc.

Disclosure

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Mr. Connor and Ms. Power both report having no relevant affiliations or financial relationships to disclose.

Please note: The opinions expressed in this program should not be construed as those of the CE provider or ICU Medical, Inc. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.